John Newman
Stock Analyst at Canaccord Genuity
(3.72)
# 2,095
Out of 4,639 analysts
910
Total ratings
45.6%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintained: Buy | $46 | $27.67 | +66.25% | 11 | Aug 11, 2026 | |
| DCTH Delcath Systems | Reiterated: Buy | $21 | $16.67 | +25.97% | 29 | Aug 7, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $2.22 | +215.32% | 14 | Aug 7, 2026 | |
| LCTX Lineage Cell Therapeutics | Maintained: Buy | $9 | $1.13 | +696.46% | 3 | Aug 6, 2026 | |
| MCRB Seres Therapeutics | Maintained: Buy | $22 | $5.00 | +340.00% | 69 | Aug 6, 2026 | |
| ACET Adicet Bio | Maintained: Buy | $18 | $8.11 | +121.95% | 28 | Aug 6, 2026 | |
| RLAY Relay Therapeutics | Maintained: Buy | $29 | $19.94 | +45.44% | 2 | Aug 6, 2026 | |
| XNCR Xencor | Maintained: Buy | $38 | $21.58 | +76.09% | 12 | Aug 5, 2026 | |
| BNTX BioNTech SE | Rated: Buy | $158 → $142 | $92.80 | +53.02% | 24 | Aug 5, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $50 | $26.25 | +90.48% | 12 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $875 | $808.05 | +8.29% | 118 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $9.28 | +147.84% | 3 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.15 | +595.65% | 13 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $10.50 | +138.10% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.10 | +566.67% | 37 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $8.61 | +50.99% | 90 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.8028 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.66 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $300 | $7.36 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $8.76 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $44 | $32.59 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $0.0025 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $353.05 | $19.68 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $24.86 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $12.55 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.794 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13.93 | $10.20 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.51 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $6 | $1.43 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $64.23 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $15.45 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $17.33 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $14.10 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $1.36 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $2.10 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $11.48 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $5.73 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $30.66 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.64 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $34.07 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $861.00 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $6 | $1.41 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $256.52 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $6.84 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $7.05 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $207.13 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $3.93 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $80.43 | n/a | 1 | Jun 10, 2009 |
Tango Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $46
Current: $27.67
Upside: +66.25%
Delcath Systems
Aug 7, 2026
Reiterated: Buy
Price Target: $21
Current: $16.67
Upside: +25.97%
Compass Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $2.22
Upside: +215.32%
Lineage Cell Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $9
Current: $1.13
Upside: +696.46%
Seres Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $22
Current: $5.00
Upside: +340.00%
Adicet Bio
Aug 6, 2026
Maintained: Buy
Price Target: $18
Current: $8.11
Upside: +121.95%
Relay Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $29
Current: $19.94
Upside: +45.44%
Xencor
Aug 5, 2026
Maintained: Buy
Price Target: $38
Current: $21.58
Upside: +76.09%
BioNTech SE
Aug 5, 2026
Rated: Buy
Price Target: $158 → $142
Current: $92.80
Upside: +53.02%
Tyra Biosciences
Aug 3, 2026
Maintained: Buy
Price Target: $50
Current: $26.25
Upside: +90.48%
Jul 22, 2026
Maintained: Buy
Price Target: $875
Current: $808.05
Upside: +8.29%
Jul 8, 2026
Maintained: Buy
Price Target: $23
Current: $9.28
Upside: +147.84%
Jun 29, 2026
Maintained: Buy
Price Target: $8
Current: $1.15
Upside: +595.65%
May 18, 2026
Maintained: Buy
Price Target: $25
Current: $10.50
Upside: +138.10%
May 14, 2026
Maintained: Buy
Price Target: $14
Current: $2.10
Upside: +566.67%
May 13, 2026
Maintained: Buy
Price Target: $13
Current: $8.61
Upside: +50.99%
Nov 12, 2024
Maintained: Buy
Price Target: $5
Current: $0.8028
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10
Current: $3.66
Upside: n/a
Oct 1, 2024
Maintained: Buy
Price Target: $6 → $300
Current: $7.36
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $43
Current: $8.76
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $52 → $44
Current: $32.59
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $7 → $3
Current: $0.0025
Upside: n/a
May 26, 2021
Maintained: Buy
Price Target: $353.05
Current: $19.68
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $31
Current: $24.86
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $45
Current: $12.55
Upside: n/a
Mar 25, 2021
Maintained: Buy
Price Target: $5
Current: $0.794
Upside: n/a
Mar 9, 2020
Maintained: Buy
Price Target: $13.93
Current: $10.20
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $1.51
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $31 → $6
Current: $1.43
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $64.23
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $15.45
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $17.33
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $14.10
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $1.36
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $2.10
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $11.48
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $5.73
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $30.66
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $3.64
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $34.07
Upside: n/a
Mar 31, 2016
Maintained: Buy
Price Target: $18
Current: $861.00
Upside: n/a
Mar 9, 2015
Maintained: Hold
Price Target: $8 → $6
Current: $1.41
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $256.52
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $6.84
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $7.05
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $207.13
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $3.93
Upside: n/a
Jun 10, 2009
Maintained: Sell
Price Target: n/a
Current: $80.43
Upside: n/a